Bioceres Crop Solutions (NASDAQ:BIOX) Third Quarter 2025 Results
Key Financial Results
- Revenue: US$59.6m (down 29% from 3Q 2024).
- Net loss: US$1.30m (down by 114% from US$9.26m profit in 3Q 2024).
- US$0.021 loss per share (down from US$0.15 profit in 3Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Bioceres Crop Solutions EPS Beats Expectations, Revenues Fall Short
Revenue missed analyst estimates by 2.0%. Earnings per share (EPS) exceeded analyst estimates by 82%.
Looking ahead, revenue is forecast to grow 9.9% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in the US.
Performance of the American Chemicals industry.
The company's shares are down 3.0% from a week ago.
Balance Sheet Analysis
While earnings are important, another area to consider is the balance sheet. We've done some analysis and you can see our take on Bioceres Crop Solutions' balance sheet.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.